Form 4: ARS Pharmaceuticals' Chief Medical Officer Sarina Tanimoto Sells Shares

Sarina Tanimoto, Chief Medical Officer of ARS Pharmaceuticals, executed sales of common stock on July 9, 2024, according to a recent SEC filing.

Summary

• Sarina Tanimoto, the Chief Medical Officer of ARS Pharmaceuticals, sold shares of the company's common stock on July 9, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan established on March 31, 2023.
• Two transactions occurred, each involving the sale of 50,000 shares.
• The weighted average sale prices were $9.6177 and $9.6168 per share, respectively.
• The price range for the sales was between $9.38 and $9.81.
• Following the transactions, Tanimoto directly owns 3,407,847 shares.
• Tanimoto also has indirect ownership through various trusts, including the Richard Lowenthal Charitable Remainder UniTrust, the Lowenthal-Tanimoto Family Trust, and the Sarina Tanimoto Charitable Remainder UniTrust, as well as shares held by her spouse.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock sales by an insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to sell shares under pre-arranged plans to diversify their holdings or for personal financial planning.

Stakeholder Impact

• The stock sale could have a minor impact on shareholder sentiment, but the pre-arranged nature of the sales mitigates concerns about insider information being used.

Key Dates